Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Central Sensitization in Pain, Functionality, and Quality of Life in Cancer Patients

NCT06418399 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT06418399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06418399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Central Sensitization in Pain, Functionality, and Quality of Life in Cancer Patients
Lead sponsor
Marmara University
Phase
Observational
Overall status
Unknown status
Start date
May 20, 2024
Completion date
April 1, 2025
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

central sensitization